Eli Lilly & Co plans to invest £279 million ($364 million) in a new initiative to support UK biotechs along with a study of ...

Health Innovation Manchester and The University of Manchester has today (14 October 2024) announced a groundbreaking ...

Giving older Americans access to weight-loss medicines through the US Medicare program would cost $35 billion over nine years ...

A groundbreaking weight loss invention could soon make it possible to drop those extra pounds without a single change in your diet.

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

Researchers have unveiled a novel approach to tackle obesity by targeting fat absorption in the small intestine. The ...

Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of employers are considering covering the blockbuster weight-loss drugs ...

When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...